+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

In-Vitro ADME Services Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 To 2029

  • PDF Icon


  • 120 Pages
  • November 2021
  • Region: Global
  • Acute Market Reports
  • ID: 5614402
In-Vitro ADME Services Market is Expected to Grow at 7.6% by 2029.

ADME is the abbreviation for absorption, distribution, metabolism and elimination, a pharmacology and pharmacokinetics term that describes the disposition of a drug or compound inside the human body. ADME comprises a set of four processes that develop the performance of a drug on human tissue and ADME toxicology testing is applied for the development of a new drug. With advancement of technology and reliability of ADME testing, due to its accurate and predictable result, its usage in drug development and initial screening for novel product has increased.

Drug absorption dominates the market

In 2020, drug absorption and transport were observed as the largest segment followed by drug metabolism due to factors such as cost-efficiency, rising demand for novel technologies, and increasing research and development activities in the field of pharmaceutical and biopharmaceutical industries. Drug absorption and transport mainly involve processes such as parallel artificial membrane permeability assay (PAMPA) permeability screening, Caco-2 permeability screening, MDCK permeability, and transporter assay platform. Drug absorption and transport are followed by drug metabolism mainly due to the presence of high market demand, increasing surveillance of regulatory bodies and rising research and development activities in the field of medicine. Service providers operating in drug metabolism services help to identify the metabolic pathways, potential interactions and routes of elimination of compound at an early stage. The pharmaceutical industry has been evolving in recent years, along with several CROs and biotech companies conducting drug discovery and development programs and services in Asia-Pacific. It was also observed that broad and vital technology platform bridges efficacy and safety, the drug metabolism and pharmacokinetics has become a mature discovery function to optimize ADME properties in drug design and screening, and dramatically mitigate attrition rates during the last decades.

Asia-Pacific In-Vitro ADME services market is the fastest growing market in the world

In the base 2015, Europe forms the largest market for In-Vitro ADME services market. The factors driving the Europe In-Vitro ADME market are research and development activities being carried out in the region regarding the drug discovery and drug metabolism at the academic level. Moreover, most of the research activities are carried out in the region and not outsourced to the other regions. Asia-Pacific In-Vitro ADME services market is the fastest growing market in the world. The market is likely to grow with the increase in drug discovery efforts in the pharmaceutical industry. It is expected that the In-Vitro ADME services market in Latin America and Middle East and Africa will witness rapid growth in the given period of forecast.

Market Competition Assesment:

The key players in In-Vitro ADME Services market are Covance Inc., Sigma-Aldrich Co. LLC, Thermo Fisher Scientific, WuXiAppTec, Pharmaron/Quatient, Charles River Laboratories International, Inc.Eurofinsand

This product will be delivered within 2 business days.

Table of Contents

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global In-Vitro ADME Services Market Portraiture
2.2 Global In-Vitro ADME Services Market, by Type, 2020 (US$ Mn)
2.3 Global In-Vitro ADME Services Market, by Geography, 2020 (Value %)
Chapter 3 Market Dynamics: In Vitro ADME Services Market
3.1 In Vitro ADME Services Market Analysis
3.2 Future Market Trend: In Vitro ADME Services
3.3 Regulatory Market Scenario
3.4 Mergers and Acquisition
3.5 Market Dynamics
3.5.1 Market Divers Raising ethical concern regarding animal testing Advancement in R&D for early detection of toxicity Lack of comprehensive databases of in-vitro test methods
3.5.2 Challenges Due to predictive paradise, decline in use of in vitro testing In Vitro Models inability to Detect Autoimmunity &Immunostimulation
3.5.3 Opportunities Surge in demand of in vitro ( pre-clinical ADME Tox) method for drug development and screening and various toxicology programs
3.6 Attractive Investment Proposition
3.7 Market Share Analysis: Key In- Vitro ADME Service Providers, 2020 (%)
Chapter 4 Global In-Vitro ADME Services Market Analysis, by Type
4.1 Introduction
4.2 Solution Properties
4.3 Drug Absorption & Transport
4.4 Drug Metabolism
4.5 Drug - Drug Interactions
Chapter 5 Global In-Vitro ADME Services Market, by Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan, Singapore, South Korea and Rest of APAC)
5.5 Latin America (Mexico, Brazil and Rest of LATAM)
5.6 Middle East and Africa
Chapter 6 Company Profiles
6.1 Absorption Systems LP
6.2 Albany Molecular Research, Inc. (AMRI)
6.3 Aptagen, LLC
6.4 BIOalternatives SAS
6.6 Sigma-Aldrich Co. LLC/ MilliporeSigma
6.8 BioTeSys GmbH
6.9 Calvert Labs
6.10 XenoTech, LLC
6.11 Cyprotex PLC
6.12 Qualyst Transporter Solution, LLC
6.13 Solvo Biotechnology
6.14 TNO
6.15 WuXiAppTec
6.17 Centrillion Technology Holdings Ltd.
6.18 In Vitro ADMET Laboratories, LLC
6.19 Covance, Inc.
6.20 Quintiles IMS Holdings, Inc.
6.21 Optivia Biotechnology Inc.
6.23 PharmaronBeijing Company Ltd.
6.25 Quest Pharmaceutical Services Holdings LLC
6.26 Thermo Fisher Scientific Inc.
6.28 Charles River Laboratories International, Inc.
6.30 EurofinsCerep SA
6.31 Admescope
6.33 Agilux
6.35 Alliance Pharma
6.36 BD Biosciences
6.37 Frontage Laboratories

Companies Mentioned

  • Covance Inc.
  • Sigma-Aldrich Co. LLC
  • Thermo Fisher Scientific
  • WuXiAppTec
  • Pharmaron/Quatient
  • Charles River Laboratories International Inc.Eurofinsand